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Background
Renal scarring and renal failure remain a life-threatening
problem in children born with spinal dysraphism; in the
literature it is reported that more than 20% of these chil-
dren die within the first year of life due to renal problems.
We show that optimal treatment of the neurogenic blad-
der from birth onwards can preserve kidney function in
most spina bifida patients.
Materials and methods
We reviewed data on all newborns with spinal dysraphism
admitted to our hospital between January 1988 and June
2001. We looked at their situation at admission and at fol-
low-up, when treatment was started and the type of treat-
ment (antimuscarinic agents, continuous intermittent
catheterisation (CIC), antibiotic prophylaxis), as well as
renal function (ultrasound, DMSA scan, serum creatinin,
creatinin clearance: Schwartz formula) and bladder func-
tion (urodynamic studies). Cases were followed for a
maximum of 13 years.
Results
Data from 144 children out of a cohort of 176, could be
evaluated by the end of the study: 5 patients had pre-exist-
ing renal abnormalities; 69 patients had an overactive
sphincter 27 of the 144 patients had reflux and 6 had
renal scarring. None of these patients are currently devel-
oping end-stage renal disease. 5 of the 6 patients with
renal scarring were started on therapy with intermittent
catheterisation and antimuscarinic therapy. 63 out of 82
children with spina bifida were dry at school age (6 years).
Conclusion
Early start to therapy helps enormously in safeguarding
renal function for children born with spinal dysraphism.
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